BeiGene
BeiGene67About
No comments yet. Be the first to share your take.
What does BeiGene do?
BeOne Medicines is a global oncology company dedicated to discovering, developing, and commercializing transformative cancer medicines. They focus on advancing a broad pipeline through rigorous science, including pioneering protein degradation with CDACs and antibody drug conjugates, to serve patients worldwide. BeOne Medicines aims to build the world's leading oncology company, driven by scientific excellence and speed to reach more patients.
How much funding has BeiGene raised?
BeiGene has raised a total of $358M in funding. The most recent round on record is Secondary Offering.
Where is BeiGene headquartered?
BeiGene is headquartered in Cambridge, Massachusetts, U.S..
When was BeiGene founded?
BeiGene was founded in 2010.
What industry does BeiGene operate in?
BeiGene operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.
What is BeiGene's revenue?
StartupHub estimates BeiGene's annual revenue at $16.3M (range $8.0M to $155.5M, 28% confidence), based on comparable companies in the sector.
What is BeiGene's valuation?
StartupHub estimates BeiGene's effective valuation at $7.9B (range $5.5B to $10.3B, 25% confidence), based on comparable companies in the sector.